2011 AES Annual Meeting - 101.01 - AES Epilepsy Specialist Symposium
Program Length: 150 minutes
In this special, three-hour overview symposium, major gaps identified through the NINDS Research Benchmarks will be targeted and proposed as opportunities develop which can result in better research and treatment. Can patients be treated more aggressively in order to earlier limit or stop epilepsy? Which emerging therapies look more promising to pursue? How can co-morbidities be prevented, limited or reversed?
Chairs: Elinor Ben-Menachem, M.D., Ph.D., David Labiner, M.D., Brandy E. Fureman, Ph.D.
8:30 a.m. Benchmark Area 1: Prevent Epilepsy and its Progression.
Can the development of refractory epilepsy (with an emphasis on focal onset seizures) be prevented?
Moderator: William H Theodore, M.D.
Speakers: Anne T. Berg, Ph.D., Jerome Engel, Jr., M.D., Ph.D., Frances E. Jensen, M.D.
9:30 a.m. Benchmark Area 2: Develop new therapeutic strategies and optimize current approaches to cure. Which are the new approaches for the treatment of epilepsy that are not yet approved: What’s new in the pipeline?
Moderator: Karen S. Wilcox, Ph.D.
Speakers: Karen S. Wilcox, Ph.D., Brian Litt, M.D.,
Jack M. Parent, M.D.
10:30 a.m. Benchmark Area 3: Prevent, limit, and reverse the comorbidities associated with epilepsy and its treatment.
Addressing critical comorbidites of epilepsy
Moderator: Bruce P. Hermann, Ph.D.
Speakers: Elson L. So, M.D. (SUDEP), W. Curt LaFrance, Jr., M.D., M.P.H., David W. Loring, Ph.D.